Lanadelumab Injection Treatment For The Prevention Of Hereditary Angioedema (HAE): Design, Development And Place In Therapy
Maria Bova,1 Anna Valerieva,2 Maddalena Alessandra Wu,3 Riccardo Senter,4 Francesca Perego5 1Department of Translational Medical Sciences and Interdepartmental Center for Research in Basic and Clinical Immunology Sciences, University of Naples Federico II, Naples, Italy; 2Clinical Centre of Allergol...
Saved in:
Main Authors: | Bova M (Author), Valerieva A (Author), Wu MA (Author), Senter R (Author), Perego F (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevention of Recurrent Attacks of Hereditary Angioedema (HAE): Berotralstat and Its Oral Bioavailability
by: Diaz-Menindez M, et al.
Published: (2023) -
Network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema
by: Maureen Watt, et al.
Published: (2023) -
Letter in reply: network meta-analysis for indirect comparison of lanadelumab and for the treatment of hereditary angioedema
by: Maureen Watt, et al.
Published: (2024) -
Letter to the editor: network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema
by: Max Schlueter, et al.
Published: (2024) -
Hereditary Angioedema
by: A.P. Volokha
Published: (2014)